Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maxinutrition is a prominent UK-based sports nutrition company that specializes in the development and commercialization of protein-based supplements and performance products. Originally founded in 1995 as Maximuscle, the company established itself as a market leader in Europe by providing drug-screened, scientifically formulated powders, bars, and beverages for athletes. The business was acquired by GlaxoSmithKline (GSK) in 2011 to expand its consumer healthcare portfolio before being sold to the Krüger Group in 2020. Today, it continues to operate as a major brand in the fitness and wellness sector, focusing on high-quality protein supplements and sports recovery solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maxinutrition.